SUMITOMO PHARMA AM

2 marketed ·

Quick facts

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about SUMITOMO PHARMA AM

What are SUMITOMO PHARMA AM's marketed drugs?

Top marketed products include Eslicarbazepine Acetate, Aptiom.

Related